Antisense Oligonucleotide
Antisense Oligonucleotide (ASO) is a synthetic polymer. It is a single-stranded deoxyribonucleotide, which is complementary to the mRNA target. Antisense oligonucleotides may be used to block the production of proteins needed for cell growth.
-
FEB 24, 2021 7:00 AM PST
FEB 24, 2021 7:00 AM PSTDate: February 24, 2021 Time: 7:00am (PST) Nucleotide variants can cause functional changes by altering protein–RNA binding in various ways that are not easy to predict. This can affec...Speaker: Thomas Doktor, PhD.Sponsored By: GenScriptDEC 09, 2020 7:00 AM PSTC.E. CREDITS
DEC 09, 2020 7:00 AM PSTDate: December 9, 2020 Time: 7:00am (PST), 10:00am (EST) In this talk we will discuss the new analytical approaches to characterize RNA molecules from small oligonucleotides to larger messen...Speaker: Stephen Lock, PhDSponsored By: SCIEXOCT 30, 2014 7:30 AM PDT
OCT 30, 2014 7:30 AM PDTFusion genes play a central role in many cancer types. They have been used to classify malignancy, risk factors, disease prognosis, and companion diagnostic biomarkers for certain approved dr...Speaker: Nicola Normanno, MDPresented at: Cancer: Research, Discovery and TherapeuticsOCT 16, 2013 6:00 AM PDT
OCT 16, 2013 6:00 AM PDTThe knowledge of molecular alterations involved in colon carcinoma (CRC) and non-small-cell lung carcinoma (NSCLC) has significantly increased in the past few years. Molecular subgroups of t...Speaker: Nicola Normanno, MDPresented at: Cancer: Research, Discovery and Therapeutics 2013AUG 21, 2013 4:00 PM PDTC.E. CREDITS
AUG 21, 2013 4:00 PM PDTHigh throughput transcriptomic analyses have shown that most of the human genome is dynamically transcribed to produce an extraordinary range of overlapping and interlacing intronic, intergen...Speaker: John Mattick, PhD,AO, FAA, FRCPAPresented at: Genetics and Genomics 2013
FEB 24, 2021
7:00 AM PST
FEB 24, 2021
7:00 AM PST
Date: February 24, 2021 Time: 7:00am (PST) Nucleotide variants can cause functional changes by altering protein–RNA binding in various ways that are not easy to predict. This can affec...
Speaker:
Thomas Doktor, PhD.
Sponsored By: GenScript
DEC 09, 2020
7:00 AM PST
C.E. CREDITS
DEC 09, 2020
7:00 AM PST
Date: December 9, 2020 Time: 7:00am (PST), 10:00am (EST) In this talk we will discuss the new analytical approaches to characterize RNA molecules from small oligonucleotides to larger messen...
Speaker:
Stephen Lock, PhD
Sponsored By: SCIEX
OCT 30, 2014
7:30 AM PDT
OCT 30, 2014
7:30 AM PDT
Fusion genes play a central role in many cancer types. They have been used to classify malignancy, risk factors, disease prognosis, and companion diagnostic biomarkers for certain approved dr...
Speaker:
Nicola Normanno, MD
Presented at: Cancer: Research, Discovery and Therapeutics
OCT 16, 2013
6:00 AM PDT
OCT 16, 2013
6:00 AM PDT
The knowledge of molecular alterations involved in colon carcinoma (CRC) and non-small-cell lung carcinoma (NSCLC) has significantly increased in the past few years. Molecular subgroups of t...
Speaker:
Nicola Normanno, MD
Presented at: Cancer: Research, Discovery and Therapeutics 2013
AUG 21, 2013
4:00 PM PDT
C.E. CREDITS
AUG 21, 2013
4:00 PM PDT
High throughput transcriptomic analyses have shown that most of the human genome is dynamically transcribed to produce an extraordinary range of overlapping and interlacing intronic, intergen...
Speaker:
John Mattick, PhD,AO, FAA, FRCPA
Presented at: Genetics and Genomics 2013
- Nerve
- Muscle
- Protein
- Functional Medicine
- Cell
- Drug Development
- Disease
- Gene
- Molecular Genetics
- Publishing
- Research and Development
- Research
- University
- DNA Damage
- Antisense RNA
- Clinical Medicine
- ALS
- Health
- T-Cells
- Clinical Genetics
- Human Genetics
- Therapy
- Mutation
- DNA
- Neuron
- Lipid
- Drug Discovery
- Adipose Tissue
- Bacteria